Applied DNA Sciences Expands Patent Portfolio

Applied DNA’s U.S. and global patent portfolio now totals 44, with 84 applications pending.

By  on February 21, 2017

Applied DNA Sciences has significantly expanded its U.S. and global patent portfolio, demonstrating its ongoing commitment to innovation in biotechnology-driven solutions to help protect the textile supply chain from theft, counterfeiting, fraud and diversion.Applied DNA’s U.S. and global patent portfolio now totals 44 issued patents, with 84 applications pending. In 2016, Applied DNA was granted new patents in broad, long-term protection for its core business verticals, including its FiberTyping, SigNature DNA, SigNature T and BackTrack platforms, as well as its bulk DNA production services.One new U.S. patent is based upon Applied DNA’s ground-breaking research in the genotyping of mature cotton fibers and provides strong protection of Applied DNA’s FiberTyping services currently utilized by major U.S. retailers and brands, as well as SigNature T supply chain partners. Two other U.S. patents provide further protection for Applied DNA’s SigNature DNA molecular taggant and the SigNature T platform, and their use in a broad range of markets, including pharmaceuticals, consumer products, industrial materials, printing and electronics.Another U.S. patent is for the first in a new family of patents that protects the encoding and decoding of information within the two-diminsional curves of a pattern, such as a military camouflage pattern. A Canadian patent extends Applied DNA’s protection of its bulk DNA production apparatus and methods to Canada.“The continuous development of our intellectual property to advance the commercial adoption of our core technology platform, SigNature DNA, is central to our business model," said James Hayward, president and chief executive officer of Applied DNA, based on Stony Brook, N.Y. "These new patents and others under examination underpin our penetration of core business verticals with an uncopyable and unbreakable mark that can reduce risk and uncertainty across global supply chains. Our intellectual property estate is among our most valuable assets and we will look to further leverage this asset in the future.”Clay D. Shorrock, general counsel for Applied DNA, said, “Our patents continue to validate our core technologies and confer a significant competitive advantage to the company. As we continue to innovate across our business lines, our patent portfolio is well positioned for substantial growth in 2017 and beyond.”
Patented botanical DNA solutions can be used to identify, tag, track and trace products, to help assure authenticity, traceability and quality of products, and provide a forensic chain of evidence that can be used to prosecute perpetrators.

To continue reading this article...

To Read the Full Article

Tap into our Global Network

Of Industry Leaders and Designers

load comments
blog comments powered by Disqus


Today's Must Read


EXCLUSIVE: Karlie Kloss' Estée Lauder Deal Goes Deep

clock 6hEllen Thomas

Social Studies